Imaging phenotypes of major depressive disorder: Genetic correlates

Neuroscience

Volumn 164, Issue 1, 2009, Pages 300-330

  Savitz, J B ^a   Drevets, W C ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

5 HT1A receptor; Endophenotype; Epigenetics; Genome wide association; Major depressive disorder; Serotonin transporter

Indexed keywords

ANIMAL; BIOLOGICAL MODEL; BRAIN; BRAIN MAPPING; GENETICS; HUMAN; MAJOR DEPRESSION; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW; SCINTISCANNING;

ANIMALS; BRAIN; BRAIN MAPPING; DEPRESSIVE DISORDER, MAJOR; HUMANS; MODELS, GENETIC; PHENOTYPE;

EID: 74049093658     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.03.082     Document Type: Review

References (364)

1. Aalto S., Naatanen P., Wallius E., Metsahonkala L., Stenman H., Niem P.M., Karlsson H. Neuroanatomical substrata of amusement and sadness: a PET activation study using film stimuli. Neuroreport 2002, 13:67-73.
2. Abler B., Erk S., Herwig U., Walter H. Anticipation of aversive stimuli activates extended amygdala in unipolar depression. J Psychiatr Res 2007, 41:511-522.
3. Alexopoulos G.S., Meyers B.S., Young R.C., Campbell S., Silbersweig D., Charlson M. Vascular depression' hypothesis. Arch Gen Psychiatry 1997, 54:915-922.
4. Alpert J.E., Fava M., Uebelacker L.A., Nierenberg A.A., Pava J.A., Worthington J.J., Rosenbaum J.F. Patterns of axis I comorbidity in early-onset versus late-onset major depressive disorder. Biol Psychiatry 1999, 46:202-211.
5. Anand A., Li Y., Wang Y., Wu J., Gao S., Bukhari L., Mathews V.P., Kalnin A., Lowe M.J. Activity and connectivity of brain mood regulating circuit in depression: a functional magnetic resonance study. Biol Psychiatry 2005, 57:1079-1088.
6. Anand A., Li Y., Wang Y., Wu J., Gao S., Bukhari L., Mathews V.P., Kalnin A., Lowe M.J. Antidepressant effect on connectivity of the mood-regulating circuit: an FMRI study. Neuropsychopharmacology 2005, 30:1334-1344.
7. Arango V., Underwood M.D., Gubbi A.V., Mann J.J. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 1995, 688:121-133.
8. Arango V., Underwood M.D., Boldrini M., Tamir H., Kassir S.A., Hsiung S., Chen J.J., Mann J.J. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 2001, 25:892-903.
9. Arce E., Simmons A.N., Lovero K.L., Stein M.B., Paulus M.P. Escitalopram effects on insula and amygdala BOLD activation during emotional processing. Psychopharmacology (Berl) 2008, 196:661-672.
10. Arranz B., Eriksson A., Mellerup E., Plenge P., Marcusson J. Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims. Biol Psychiatry 1994, 35:457-463.
11. Ashburner J., Friston K.J. Voxel-based morphometry-the methods. Neuroimage 2000, 11:805-821.
12. Ashtari M., Greenwald B.S., Kramer-Ginsberg E., Hu J., Wu H., Patel M., Aupperle P., Pollack S. Hippocampal/amygdala volumes in geriatric depression. Psychol Med 1999, 29:629-638.
13. Aston C., Jiang L., Sokolov B.P. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry 2005, 10:309-322.
14. Axelson D.A., Doraiswamy P.M., McDonald W.M., Boyko O.B., Tupler L.A., Patterson L.J., Nemeroff C.B., Ellinwood E.H., Krishnan K.R. Hypercortisolemia and hippocampal changes in depression. Psychiatry Res 1993, 47:163-173.
15. Aylward E.H., Minshew N.J., Goldstein G., Honeycutt N.A., Augustine A.M., Yates K.O., Barta P.E., Pearlson G.D. MRI volumes of amygdala and hippocampus in non-mentally retarded autistic adolescents and adults. Neurology 1999, 53:2145-2150.
16. Bachevalier J., Loveland K.A. The orbitofrontal-amygdala circuit and self-regulation of social-emotional behavior in autism. Neurosci Biobehav Rev 2006, 30:97-117.
17. Ballmaier M., Narr K.L., Toga A.W., Elderkin-Thompson V., Thompson P.M., Hamilton L., Haroon E., Pham D., Heinz A., Kumar A. Hippocampal morphology and distinguishing late-onset from early-onset elderly depression. Am J Psychiatry 2008, 165:229-237.
18. Barden N. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J Psychiatry Neurosci 2004, 29:185-193.
19. Becker K., El-Faddagh M., Schmidt M.H., Esser G., Laucht M. Interaction of dopamine transporter genotype with prenatal smoke exposure on ADHD symptoms. J Pediatr 2008, 152:263-269.
20. Beevers C.G., Gibb B.E., McGeary J.E., Miller I.W. Serotonin transporter genetic variation and biased attention for emotional word stimuli among psychiatric inpatients. J Abnorm Psychol 2007, 116:208-212.
21. Benkelfat C., Ellenbogen M.A., Dean P., Palmour R.M., Young S.N. Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. Arch Gen Psychiatry 1994, 51:687-697.
22. Bertolino A., Arciero G., Rubino V., Latorre V., De Candia M., Mazzola V., Blasi G., Caforio G., Hariri A., Kolachana B., Nardini M., Weinberger D.R., Scarabino T. Variation of human amygdala response during threatening stimuli as a function of 5'HTTLPR genotype and personality style. Biol Psychiatry 2005, 57:1517-1525.
23. Bethea C.L., Streicher J.M., Mirkes S.J., Sanchez R.L., Reddy A.P., Cameron J.L. Serotonin-related gene expression in female monkeys with individual sensitivity to stress. Neuroscience 2005, 132:151-166.
24. 11C]WAY-100635. Mol Psychiatry 2004, 9:386-392.
25. 11C]DASB. Am J Psychiatry 2007, 164:1858-1865.
26. Blumberg H.P., Wang F., Chepenik L.G., Kalmar J.H., Edmiston E., Duman R.S., Gelernter J. Influence of vascular endothelial growth factor variation on human hippocampus morphology. Biol Psychiatry 2008, 64:901-903.
27. Boes A.D., McCormick L.M., Coryell W.H., Nopoulos P. Rostral anterior cingulate cortex volume correlates with depressed mood in normal healthy children. Biol Psychiatry 2008, 63:391-397.
28. 11C]DASB. Mov Disord 2008, 23:1776-1780.
29. Boldrini M., Underwood M.D., Mann J.J., Arango V. Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides. J Psychiatr Res 2008, 42:433-442.
30. Botteron K.N., Raichle M.E., Drevets W.C., Heath A.C., Todd R.D. Volumetric reduction in left subgenual prefrontal cortex in early onset depression. Biol Psychiatry 2002, 51:342-344.
31. Bowen D.M., Najlerahim A., Procter A.W., Francis P.T., Murphy E. Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life. Proc Natl Acad Sci U S A 1989, 86:9504-9508.
32. Brocke B., Armbruster D., Muller J., Hensch T., Jacob C.P., Lesch K.P., Kirschbaum C., Strobel A. Serotonin transporter gene variation impacts innate fear processing: acoustic startle response and emotional startle. Mol Psychiatry 2006, 11:1106-1112.
33. Brodsky B.S., Mann J.J., Stanley B., Tin A., Oquendo M., Birmaher B., Greenhill L., Kolko D., Zelazny J., Burke A.K., Melhem N.M., Brent D. Familial transmission of suicidal behavior: factors mediating the relationship between childhood abuse and offspring suicide attempts. J Clin Psychiatry 2008, 69:584-596.
34. Brody A.L., Saxena S., Stoessel P., Gillies L.A., Fairbanks L.A., Alborzian S., Phelps M.E., Huang S.C., Wu H.M., Ho M.L., Ho M.K., Au S.C., Maidment K., Baxter L.R. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry 2001, 58:631-640.
35. Brown S.M., Peet E., Manuck S.B., Williamson D.E., Dahl R.E., Ferrell R.E., Hariri A.R. A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. Mol Psychiatry 2005, 10:805. 884-888.
36. 11C] (+)McN-5652: assessment of methods. J Cereb Blood Flow Metab 2000, 20:253-262.
37. Buckholtz J.W., Callicott J.H., Kolachana B., Hariri A.R., Goldberg T.E., Genderson M., Egan M.F., Mattay V.S., Weinberger D.R., Meyer-Lindenberg A. Genetic variation in MAOA modulates ventromedial prefrontal circuitry mediating individual differences in human personality. Mol Psychiatry 2008, 13:313-324.
38. Bueller J.A., Aftab M., Sen S., Gomez-Hassan D., Burmeister M., Zubieta J.K. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry 2006, 59:812-815.
39. Caldwell K.K., Sheema S., Paz R.D., Samudio-Ruiz S.L., Laughlin M.H., Spence N.E., Roehlk M.J., Alcon S.N., Allan A.M. Fetal alcohol spectrum disorder-associated depression: evidence for reductions in the levels of brain-derived neurotrophic factor in a mouse model. Pharmacol Biochem Behav 2008, 90:614-624.
40. Canli T., Congdon E., Todd Constable R., Lesch K.P. Additive effects of serotonin transporter and tryptophan hydroxylase-2 gene variation on neural correlates of affective processing. Biol Psychol 2008, 79:118-125.
41. Canli T., Congdon E., Gutknecht L., Constable R.T., Lesch K.P. Amygdala responsiveness is modulated by tryptophan hydroxylase-2 gene variation. J Neural Transm 2005, 112:1479-1485.
42. Canli T., Omura K., Haas B.W., Fallgatter A., Constable R.T., Lesch K.P. Beyond affect: a role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task. Proc Natl Acad Sci U S A 2005, 102:12224-12229.
43. 11C]DASB; comparison with bipolar disorder. Biol Psychiatry 2007, 62:870-877.
44. Carter C.J. eIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia?. Schizophr Bull 2007, 33:1343-1353.
45. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
46. Cecil K.M., Brubaker C.J., Adler C.M., Dietrich K.N., Altaye M., Egelhoff J.C., Wessel S., Elangovan I., Hornung R., Jarvis K., Lanphear B.P. Decreased brain volume in adults with childhood lead exposure. PLoS Med 2008, 5:e112.
47. Cerasa A., Gioia M.C., Labate A., Liguori M., Lanza P., Quattrone A. Impact of catechol-O-methyltransferase Val(108/158) Met genotype on hippocampal and prefrontal gray matter volume. Neuroreport 2008, 19:405-408.
48. Chalmers D.T., Kwak S.P., Mansour A., Akil H., Watson S.J. Corticosteroids regulate brain hippocampal 5-HT1A receptor mRNA expression. J Neurosci 1993, 13:914-923.
49. Chen C.H., Ridler K., Suckling J., Williams S., Fu C.H., Merlo-Pich E., Bullmore E. Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry 2007, 62(5):407-414.
50. Chen C.H., Suckling J., Ooi C., Fu C.H., Williams S.C., Walsh N.D., Mitterschiffthaler M.T., Pich E.M., Bullmore E. Functional coupling of the amygdala in depressed patients treated with antidepressant medication. Neuropsychopharmacology 2008, 33:1909-1918.
51. Chen P.S., McQuoid D.R., Payne M.E., Steffens D.C. White matter and subcortical gray matter lesion volume changes and late-life depression outcome: a 4-year magnetic resonance imaging study. Int Psychogeriatr 2006, 18:445-456.
52. Chepenik L.G., Fredericks C., Papademetris X., Spencer L., Lacadie C., Wang F., Pittman B., Duncan J.S., Staib L.H., Duman R.S., Gelernter J., Blumberg H.P. Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder. Neuropsychopharmacology 2009, 34:944-951.
53. Coffey C.E., Figiel G.S., Djang W.T., Saunders W.B., Weiner R.D. White matter hyperintensity on magnetic resonance imaging: clinical and neuroanatomic correlates in the depressed elderly. J Neuropsychiatry Clin Neurosci 1989, 1:135-144.
54. Convit A., de Leon M.J., Tarshish C., De Santi S., Kluger A., Rusinek H., George A.E. Hippocampal volume losses in minimally impaired elderly. Lancet 1995, 345:266.
55. Coryell W., Nopoulos P., Drevets W., Wilson T., Andreasen N.C. Subgenual prefrontal cortex volumes in major depressive disorder and schizophrenia: diagnostic specificity and prognostic implications. Am J Psychiatry 2005, 162:1706-1712.
56. Danese A., Moffitt T.E., Pariante C.M., Ambler A., Poulton R., Caspi A. Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch Gen Psychiatry 2008, 65:409-415.
57. Dannlowski U., Ohrmann P., Bauer J., Kugel H., Arolt V., Heindel W., Kersting A., Baune B.T., Suslow T. Amygdala reactivity to masked negative faces is associated with automatic judgmental bias in major depression: a 3 T fMRI study. J Psychiatry Neurosci 2007, 32:423-429.
58. Dannlowski U., Ohrmann P., Bauer J., Kugel H., Baune B.T., Hohoff C., Kersting A., Arolt V., Heindel W., Deckert J., Suslow T. Serotonergic genes modulate amygdala activity in major depression. Genes Brain Behav 2007, 6:672-676.
59. Dannlowski U., Ohrmann P., Bauer J., Deckert J., Hohoff C., Kugel H., Arolt V., Heindel W., Kersting A., Baune B.T., Suslow T. 5-HTTLPR biases amygdala activity in response to masked facial expressions in major depression. Neuropsychopharmacology 2008, 33:418-424.
60. Dannlowski U., Ohrmann P., Konrad C., Domschke K., Bauer J., Kugel H., Hohoff C., Schoning S., Kersting A., Baune B.T., Mortensen L.S., Arolt V., Zwitserlood P., Deckert J., Heindel W., Suslow T. Reduced amygdala-prefrontal coupling in major depression: association with MAOA genotype and illness severity. Int J Neuropsychopharmacol 2009, 12:11-22.
61. David S.P., Murthy N.V., Rabiner E.A., Munafo M.R., Johnstone E.C., Jacob R., Walton R.T., Grasby P.M. A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J Neurosci 2005, 25:2586-2590.
62. Davidson R.J., Irwin W., Anderle M.J., Kalin N.H. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 2003, 160:64-75.
63. de Souza Lisboa S.F., Goncalves G., Komatsu F., Queiroz C.A., Almeida A.A., Moreira E.G. Developmental lead exposure induces depressive-like behavior in female rats. Drug Chem Toxicol 2005, 28:67-77.
64. Dickerson F.B., Boronow J.J., Stallings C., Origoni A.E., Cole S., Leister F., Krivogorsky B., Yolken R.H. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder. Bipolar Disord 2006, 8:124-132.
65. Dickie E.W., Armony J.L. Amygdala responses to unattended fearful faces: interaction between sex and trait anxiety. Psychiatry Res 2008, 162:51-57.
66. Domschke K., Braun M., Ohrmann P., Suslow T., Kugel H., Bauer J., Hohoff C., Kersting A., Engelien A., Arolt V., Heindel W., Deckert J. Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. Int J Neuropsychopharmacol 2006, 9:349-355.
67. Domschke K., Ohrmann P., Braun M., Suslow T., Bauer J., Hohoff C., Kersting A., Engelien A., Arolt V., Heindel W., Deckert J., Kugel H. Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder. Psychiatry Res 2008, 163:13-20.
68. Drevets W.C., Bogers W., Raichle M.E. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol 2002, 12:527-544.
69. Drevets W.C., Savitz J., Trimble M. The subgenual anterior cingulate cortex in mood disorders. CNS Spectr 2008, 13:663-681.
70. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Greer P.J., Mathis C. Serotonin type-1A receptor imaging in depression. Nucl Med Biol 2000, 27:499-507.
71. Drevets W.C., Price J.L., Simpson J.R., Todd R.D., Reich T., Vannier M., Raichle M.E. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997, 386:824-827.
72. Drevets W.C., Price J.L., Simpson J.R., Todd R.D., Reich T., Vannier M., Raichle M.E. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997, 386:824-827.
73. Drevets W.C., Thase M.E., Moses-Kolko E.L., Price J., Frank E., Kupfer D.J., Mathis C. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol 2007, 34:865-877.
74. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Holt D., Greer P.J., Huang Y., Gautier C., Mathis C. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 1999, 46:1375-1387.
75. Ducci F., Enoch M.A., Hodgkinson C., Xu K., Catena M., Robin R.W., Goldman D. Interaction between a functional MAOA locus and childhood sexual abuse predicts alcoholism and antisocial personality disorder in adult women. Mol Psychiatry 2008, 13:334-347.
76. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006, 59:1116-1127.
77. Dupont R.M., Butters N., Schafer K., Wilson T., Hesselink J., Gillin J.C. Diagnostic specificity of focal white matter abnormalities in bipolar and unipolar mood disorder. Biol Psychiatry 1995, 38:482-486.
78. Dupont R.M., Jernigan T.L., Heindel W., Butters N., Shafer K., Wilson T., Hesselink J., Gillin J.C. Magnetic resonance imaging and mood disorders. Localization of white matter and other subcortical abnormalities. Arch Gen Psychiatry 1995, 52:747-755.
79. Eaton W.W., Shao H., Nestadt G., Lee B.H., Bienvenu O.J., Zandi P. Population-based study of first onset and chronicity in major depressive disorder. Arch Gen Psychiatry 2008, 65:513-520.
80. Etkin A., Klemenhagen K.C., Dudman J.T., Rogan M.T., Hen R., Kandel E.R., Hirsch J. Individual differences in trait anxiety predict the response of the basolateral amygdala to unconsciously processed fearful faces. Neuron 2004, 44:1043-1055.
81. Fakra E., Hyde L.W., Gorka A., Fisher P.M., Munoz K.E., Kimak M., Halder I., Ferrell R.E., Manuck S.B., Hariri A.R. Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety. Arch Gen Psychiatry 2009, 66:33-40.
82. Fales C.L., Barch D.M., Rundle M.M., Mintun M.A., Snyder A.Z., Cohen J.D., Mathews J., Sheline Y.I. Altered emotional interference processing in affective and cognitive-control brain circuitry in major depression. Biol Psychiatry 2008, 63:377-384.
83. Fatemi S.H., Reutiman T.J., Folsom T.D., Huang H., Oishi K., Mori S., Smee D.F., Pearce D.A., Winter C., Sohr R., Juckel G. Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr Res 2008, 99:56-70.
84. Fertuzinhos S.M., Oliveira J.R., Nishimura A.L., Pontual D., Carvalho D.R., Sougey E.B., Otto P.A., Zatz M. Analysis of IL-1alpha, IL-1beta, and IL-1RA [correction of IL-RA] polymorphisms in dysthymia. J Mol Neurosci 2004, 22:251-256.
85. Fitzgerald E.F., Belanger E.E., Gomez M.I., Cayo M., McCaffrey R.J., Seegal R.F., Jansing R.L., Hwang S.A., Hicks H.E. Polychlorinated biphenyl exposure and neuropsychological status among older residents of upper Hudson River communities. Environ Health Perspect 2008, 116:209-215.
86. Flugge G., Kramer M., Rensing S., Fuchs E. 5HT1A-receptors and behaviour under chronic stress: selective counteraction by testosterone. Eur J Neurosci 1998, 10:2685-2693.
87. Ford D.E., Erlinger T.P. Depression and C-reactive protein in US adults: data from the third national health and nutrition examination survey. Arch Intern Med 2004, 164:1010-1014.
88. Fornito A., Whittle S., Wood S.J., Velakoulis D., Pantelis C., Yucel M. The influence of sulcal variability on morphometry of the human anterior cingulate and paracingulate cortex. Neuroimage 2006, 33:843-854.
89. Fox A.S., Shelton S.E., Oakes T.R., Davidson R.J., Kalin N.H. Trait-like brain activity during adolescence predicts anxious temperament in primates. PLoS ONE 2008, 3:e2570.
90. Frodl T., Meisenzahl E.M., Zetzsche T., Born C., Groll C., Jager M., Leinsinger G., Bottlender R., Hahn K., Moller H.J. Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry 2002, 159:1112-1118.
91. Frodl T., Zill P., Baghai T., Schule C., Rupprecht R., Zetzsche T., Bondy B., Reiser M., Moller H.J., Meisenzahl E.M. Reduced hippocampal volumes associated with the long variant of the tri- and diallelic serotonin transporter polymorphism in major depression. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1003-1007.
92. Frodl T.S., Koutsouleris N., Bottlender R., Born C., Jager M., Scupin I., Reiser M., Moller H.J., Meisenzahl E.M. Depression-related variation in brain morphology over 3 years: effects of stress?. Arch Gen Psychiatry 2008, 65:1156-1165.
93. Frodl T., Meisenzahl E.M., Zetzsche T., Hohne T., Banac S., Schorr C., Jager M., Leinsinger G., Bottlender R., Reiser M., Moller H.J. Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. J Clin Psychiatry 2004, 65:492-499.
94. Frodl T., Meisenzahl E.M., Zill P., Baghai T., Rujescu D., Leinsinger G., Bottlender R., Schule C., Zwanzger P., Engel R.R., Rupprecht R., Bondy B., Reiser M., Moller H.J. Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Arch Gen Psychiatry 2004, 61:177-183.
95. Frodl T., Schule C., Schmitt G., Born C., Baghai T., Zill P., Bottlender R., Rupprecht R., Bondy B., Reiser M., Moller H.J., Meisenzahl E.M. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry 2007, 64:410-416.
96. Frodl T., Schaub A., Banac S., Charypar M., Jager M., Kummler P., Bottlender R., Zetzsche T., Born C., Leinsinger G., Reiser M., Moller H.J., Meisenzahl E.M. Reduced hippocampal volume correlates with executive dysfunctioning in major depression. J Psychiatry Neurosci 2006, 31:316-323.
97. Frokjaer V.G., Vinberg M., Erritzoe D., Svarer C., Baare W., Budtz-Joergensen E., Madsen K., Madsen J., Kessing L.V., Knudsen G.M. High familial risk for mood disorder is associated with low dorsolateral prefrontal cortex serotonin transporter binding. Neuroimage 2009, 46:360-366.
98. Fu C.H., Williams S.C., Cleare A.J., Scott J., Mitterschiffthaler M.T., Walsh N.D., Donaldson C., Suckling J., Andrew C., Steiner H., Murray R.M. Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol Psychiatry 2008, 64:505-512.
99. Fu C.H., Williams S.C., Cleare A.J., Brammer M.J., Walsh N.D., Kim J., Andrew C.M., Pich E.M., Williams P.M., Reed L.J., Mitterschiffthaler M.T., Suckling J., Bullmore E.T. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 2004, 61:877-889.
100. Fujita M., Imaizumi M., Zoghbi S.S., Fujimura Y., Farris A.G., Suhara T., Hong J., Pike V.W., Innis R.B. Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation. Neuroimage 2008, 40:43-52.
101. Furmark T., Tillfors M., Garpenstrand H., Marteinsdottir I., Langstrom B., Oreland L., Fredrikson M. Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia. Neurosci Lett 2004, 362:189-192.
102. Furmark T., Appel L., Henningsson S., Ahs F., Faria V., Linnman C., Pissiota A., Frans O., Bani M., Bettica P., Pich E.M., Jacobsson E., Wahlstedt K., Oreland L., Langstrom B., Eriksson E., Fredrikson M. A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. J Neurosci 2008, 28:13066-13074.
103. Gallinat J., Strohle A., Lang U.E., Bajbouj M., Kalus P., Montag C., Seifert F., Wernicke C., Rommelspacher H., Rinneberg H., Schubert F. Association of human hippocampal neurochemistry, serotonin transporter genetic variation, and anxiety. Neuroimage 2005, 26:123-131.
104. Gatt J.M., Nemeroff C.B., Dobson-Stone C., Paul R.H., Bryant R.A., Schofield P.R., Gordon E., Kemp A.H., Williams L.M. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry 2009, in press.
105. George M.S., Ketter T.A., Parekh P.I., Horwitz B., Herscovitch P., Post R.M. Brain activity during transient sadness and happiness in healthy women. Am J Psychiatry 1995, 152:341-351.
106. Gloor P., Olivier A., Quesney L.F., Andermann F., Horowitz S. The role of the limbic system in experiential phenomena of temporal lobe epilepsy. Ann Neurol 1982, 12:129-144.
107. Godin O., Dufouil C., Maillard P., Delcroix N., Mazoyer B., Crivello F., Alperovitch A., Tzourio C. White matter lesions as a predictor of depression in the elderly: the 3C-Dijon study. Biol Psychiatry 2008, 63:663-669.
108. Goldapple K., Segal Z., Garson C., Lau M., Bieling P., Kennedy S., Mayberg H. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 2004, 61:34-41.
109. Gotlib I.H., Sivers H., Gabrieli J.D., Whitfield-Gabrieli S., Goldin P., Minor K.L., Canli T. Subgenual anterior cingulate activation to valenced emotional stimuli in major depression. Neuroreport 2005, 16:1731-1734.
110. Gottesman I.I., Shields J. Genetic theorizing and schizophrenia. Br J Psychiatry 1973, 122:15-30.
111. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003, 160:636-645.
112. Grecksch G., Zhou D., Franke C., Schroder U., Sabel B., Becker A., Huether G. Influence of olfactory bulbectomy and subsequent imipramine treatment on 5-hydroxytryptaminergic presynapses in the rat frontal cortex: behavioural correlates. Br J Pharmacol 1997, 122:1725-1731.
113. Greenwald B.S., Kramer-Ginsberg E., Krishnan R.R., Ashtari M., Aupperle P.M., Patel M. MRI signal hyperintensities in geriatric depression. Am J Psychiatry 1996, 153:1212-1215.
114. Greenwald B.S., Kramer-Ginsberg E., Krishnan K.R., Ashtari M., Auerbach C., Patel M. Neuroanatomic localization of magnetic resonance imaging signal hyperintensities in geriatric depression. Stroke 1998, 29:613-617.
115. Greicius M.D., Flores B.H., Menon V., Glover G.H., Solvason H.B., Kenna H., Reiss A.L., Schatzberg A.F. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol Psychiatry 2007, 62:429-437.
116. Gronli J., Bramham C., Murison R., Kanhema T., Fiske E., Bjorvatn B., Ursin R., Portas C.M. Chronic mild stress inhibits BDNF protein expression and CREB activation in the dentate gyrus but not in the hippocampus proper. Pharmacol Biochem Behav 2006, 85:842-849.
117. Guze B.H., Szuba M.P. Leukoencephalopathy and major depression: a preliminary report. Psychiatry Res 1992, 45:169-175.
118. Habel U., Klein M., Kellermann T., Shah N.J., Schneider F. Same or different?. Neural correlates of happy and sad mood in healthy males. Neuroimage 2005, 26:206-214.
119. Hamilton J.P., Gotlib I.H. Neural substrates of increased memory sensitivity for negative stimuli in major depression. Biol Psychiatry 2008, 63:1155-1162.
120. Hammen C., Brennan P.A., Keenan-Miller D., Herr N.R. Early onset recurrent subtype of adolescent depression: clinical and psychosocial correlates. J Child Psychol Psychiatry 2008, 49:433-440.
121. Hannestad J., Taylor W.D., McQuoid D.R., Payne M.E., Krishnan K.R., Steffens D.C., Macfall J.R. White matter lesion volumes and caudate volumes in late-life depression. Int J Geriatr Psychiatry 2006, 21:1193-1198.
122. Hare T.A., Tottenham N., Galvan A., Voss H.U., Glover G.H., Casey B.J. Biological substrates of emotional reactivity and regulation in adolescence during an emotional go-nogo task. Biol Psychiatry 2008, 63:927-934.
123. Hariri A.R., Drabant E.M., Munoz K.E., Kolachana B.S., Mattay V.S., Egan M.F., Weinberger D.R. A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry 2005, 62:146-152.
124. Hariri A.R., Mattay V.S., Tessitore A., Kolachana B., Fera F., Goldman D., Egan M.F., Weinberger D.R. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002, 297:400-403.
125. Harmer C.J., Mackay C.E., Reid C.B., Cowen P.J., Goodwin G.M. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry 2006, 59:816-820.
126. Hasler G., Fromm S., Carlson P.J., Luckenbaugh D.A., Waldeck T., Geraci M., Roiser J.P., Neumeister A., Meyers N., Charney D.S., Drevets W.C. Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Arch Gen Psychiatry 2008, 65:521-531.
127. Hastings R.S., Parsey R.V., Oquendo M.A., Arango V., Mann J.J. Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression. Neuropsychopharmacology 2004, 29:952-959.
128. Heinz A., Smolka M.N., Braus D.F., Wrase J., Beck A., Flor H., Mann K., Schumann G., Buchel C., Hariri A.R., Weinberger D.R. Serotonin transporter genotype (5-HTTLPR): effects of neutral and undefined conditions on amygdala activation. Biol Psychiatry 2007, 61:1011-1014.
129. Heinz A., Braus D.F., Smolka M.N., Wrase J., Puls I., Hermann D., Klein S., Grusser S.M., Flor H., Schumann G., Mann K., Buchel C. Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci 2005, 8:20-21.
130. Herscovitch P. Cerebral physiologic measurements with PET. Positron emission tomography: basic science and clinical practice 2003, 283-308. Springer, London. P.E. Valk, D.L. Bailey, D.W. Townsend, M.N. Maisey (Eds.).
131. Hettema J.M., An S.S., van den Oord E.J., Neale M.C., Kendler K.S., Chen X. Association study between the serotonin 1A receptor (HTR1A) gene and neuroticism, major depression, and anxiety disorders. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:661-666.
132. Hickie I., Scott E., Mitchell P., Wilhelm K., Austin M.P., Bennett B. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 1995, 37:151-160.
133. Hickie I., Naismith S., Ward P.B., Turner K., Scott E., Mitchell P., Wilhelm K., Parker G. Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression. Br J Psychiatry 2005, 186:197-202.
134. Hirvonen J., Karlsson H., Kajander J., Lepola A., Markkula J., Rasi-Hakala H., Nagren K., Salminen J.K., Hietala J. Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. Int J Neuropsychopharmacol 2008, 11:465-476.
135. Ho B.C., Milev P., O'Leary D.S., Librant A., Andreasen N.C., Wassink T.H. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry 2006, 63:731-740.
136. Hoffman B.J., Hansson S.R., Mezey E., Palkovits M. Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system. Front Neuroendocrinol 1998, 19:187-231.
137. Holthoff V.A., Beuthien-Baumann B., Zundorf G., Triemer A., Ludecke S., Winiecki P., Koch R., Fuchtner F., Herholz K. Changes in brain metabolism associated with remission in unipolar major depression. Acta Psychiatr Scand 2004, 110:184-194.
138. Hu X.Z., Lipsky R.H., Zhu G., Akhtar L.A., Taubman J., Greenberg B.D., Xu K., Arnold P.D., Richter M.A., Kennedy J.L., Murphy D.L., Goldman D. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 2006, 78:815-826.
139. Huang Y.Y., Battistuzzi C., Oquendo M.A., Harkavy-Friedman J., Greenhill L., Zalsman G., Brodsky B., Arango V., Brent D.A., Mann J.J. Human 5-HT1A receptor C(-1019)G polymorphism and psychopathology. Int J Neuropsychopharmacol 2004, 7:441-451.
140. 11C] (+)McN5652. Biol Psychiatry 2002, 51:715-722.
141. Inagaki M., Matsuoka Y., Sugahara Y., Nakano T., Akechi T., Fujimori M., Imoto S., Murakami K., Uchitomi Y. Hippocampal volume and first major depressive episode after cancer diagnosis in breast cancer survivors. Am J Psychiatry 2004, 161:2263-2270.
142. Inagaki M., Yoshikawa E., Kobayakawa M., Matsuoka Y., Sugawara Y., Nakano T., Akizuki N., Fujimori M., Akechi T., Kinoshita T., Furuse J., Murakami K., Uchitomi Y. Regional cerebral glucose metabolism in patients with secondary depressive episodes after fatal pancreatic cancer diagnosis. J Affect Disord 2007, 99:231-236.
143. Inoue T., Tsuchiya K., Koyama T. Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in the rat brain. Pharmacol Biochem Behav 1994, 49:911-920.
144. Iosifescu D.V., Renshaw P.F., Lyoo I.K., Lee H.K., Perlis R.H., Papakostas G.I., Nierenberg A.A., Fava M. Brain white-matter hyperintensities and treatment outcome in major depressive disorder. Br J Psychiatry 2006, 188:180-185.
145. Jacobsen J.P., Mork A. Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat. Brain Res 2006, 1110:221-225.
146. Jacobson L., Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev 1991, 12:118-134.
147. Janssen J., Hulshoff Pol H.E., Lampe I.K., Schnack H.G., de Leeuw F.E., Kahn R.S., Heeren T.J. Hippocampal changes and white matter lesions in early-onset depression. Biol Psychiatry 2004, 56:825-831.
148. Janssen J., Hulshoff Pol H.E., de Leeuw F.E., Schnack H.S., Lampe I.K., Kok R.M., Kahn R.S., Heeren T.J. Hippocampal volume and subcortical white matter lesions in late-life depression: comparison of early- and late-onset depression. J Neurol Neurosurg Psychiatry 2007, 78:638-640.
149. Joffe R.T., Gatt J.M., Kemp A.H., Grieve S., Dobson-Stone C., Kuan S.A., Schofield P.R., Gordon E., Williams L.M. Brain derived neurotrophic factor Val66Met polymorphism, the five factor model of personality and hippocampal volume: implications for depressive illness. Hum Brain Mapp 2009, 30:1246-1256.
150. Johnstone T., van Reekum C.M., Urry H.L., Kalin N.H., Davidson R.J. Failure to regulate: counterproductive recruitment of top-down prefrontal-subcortical circuitry in major depression. J Neurosci 2007, 27:8877-8884.
151. Kalin N.H., Shelton S.E., Fox A.S., Rogers J., Oakes T.R., Davidson R.J. The serotonin transporter genotype is associated with intermediate brain phenotypes that depend on the context of eliciting stressor. Mol Psychiatry 2008, 13:1021-1027.
152. Karl A., Schaefer M., Malta L.S., Dorfel D., Rohleder N., Werner A. A meta-analysis of structural brain abnormalities in PTSD. Neurosci Biobehav Rev 2006, 30:1004-1031.
153. Kaufman J., Yang B.Z., Douglas-Palumberi H., Grasso D., Lipschitz D., Houshyar S., Krystal J.H., Gelernter J. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry 2006, 59:673-680.
154. Keck M.E., Sartori S.B., Welt T., Muller M.B., Ohl F., Holsboer F., Landgraf R., Singewald N. Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment. J Neurochem 2005, 92:1170-1179.
155. Keedwell P., Drapier D., Surguladze S., Giampietro V., Brammer M., Phillips M. Neural markers of symptomatic improvement during antidepressant therapy in severe depression: subgenual cingulate and visual cortical responses to sad, but not happy, facial stimuli are correlated with changes in symptom score. J Psychopharmacol 2008, in press.
156. Kegeles L.S., Malone K.M., Slifstein M., Ellis S.P., Xanthopoulos E., Keilp J.G., Campbell C., Oquendo M., Van Heertum R.L., Mann J.J. Response of cortical metabolic deficits to serotonergic challenge in familial mood disorders. Am J Psychiatry 2003, 160:76-82.
157. Kennedy S.H., Evans K.R., Kruger S., Mayberg H.S., Meyer J.H., McCann S., Arifuzzman A.I., Houle S., Vaccarino F.J. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry 2001, 158:899-905.
158. Kertesz A., Black S.E., Tokar G., Benke T., Carr T., Nicholson L. Periventricular and subcortical hyperintensities on magnetic resonance imaging. "Rims, caps, and unidentified bright objects.". Arch Neurol 1988, 45:404-408.
159. Kienast T., Hariri A.R., Schlagenhauf F., Wrase J., Sterzer P., Buchholz H.G., Smolka M.N., Grunder G., Cumming P., Kumakura Y., Bartenstein P., Dolan R.J., Heinz A. Dopamine in amygdala gates limbic processing of aversive stimuli in humans. Nat Neurosci 2008, 11:1381-1382.
160. Kirov G., Zaharieva I., Georgieva L., Moskvina V., Nikolov I., Cichon S., Hillmer A., Toncheva D., Owen M.J., O'Donovan M.C. A genome-wide association study in 574 schizophrenia trios using DNA pooling. Mol Psychiatry 2008, in press.
161. Koo M.S., Levitt J.J., Salisbury D.F., Nakamura M., Shenton M.E., McCarley R.W. A cross-sectional and longitudinal magnetic resonance imaging study of cingulate gyrus gray matter volume abnormalities in first-episode schizophrenia and first-episode affective psychosis. Arch Gen Psychiatry 2008, 65:746-760.
162. Kraus M.R., Al-Taie O., Schafer A., Pfersdorff M., Lesch K.P., Scheurlen M. Serotonin-1A receptor gene HTR1A variation predicts interferon-induced depression in chronic hepatitis C. Gastroenterology 2007, 132:1279-1286.
163. Kreiss D.S., Lucki I. Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei. J Pharmacol Exp Ther 1994, 269:1268-1279.
164. Krishnan K.R., Hays J.C., Blazer D.G. MRI-defined vascular depression. Am J Psychiatry 1997, 154:497-501.
165. Kronmuller K.T., Pantel J., Kohler S., Victor D., Giesel F., Magnotta V.A., Mundt C., Essig M., Schroder J. Hippocampal volume and 2-year outcome in depression. Br J Psychiatry 2008, 192:472-473.
166. Kumano H., Ida I., Oshima A., Takahashi K., Yuuki N., Amanuma M., Oriuchi N., Endo K., Matsuda H., Mikuni M. Brain metabolic changes associated with predispotion to onset of major depressive disorder and adjustment disorder in cancer patients: a preliminary PET study. J Psychiatr Res 2007, 41:591-599.
167. Kumano H., Ida I., Oshima A., Takahashi K., Yuuki N., Amanuma M., Oriuchi N., Endo K., Matsuda H., Mikuni M. Brain metabolic changes associated with predispotion to onset of major depressive disorder and adjustment disorder in cancer patients-a preliminary PET study. J Psychiatr Res 2007, 41:591-599.
168. Kumar A., Bilker W., Jin Z., Udupa J. Atrophy and high intensity lesions: complementary neurobiological mechanisms in late-life major depression. Neuropsychopharmacology 2000, 22:264-274.
169. Kwon J.S., Shin Y.W., Kim C.W., Kim Y.I., Youn T., Han M.H., Chang K.H., Kim J.J. Similarity and disparity of obsessive-compulsive disorder and schizophrenia in MR volumetric abnormalities of the hippocampus-amygdala complex. J Neurol Neurosurg Psychiatry 2003, 74:962-964.
170. Laakso M.P., Vaurio O., Koivisto E., Savolainen L., Eronen M., Aronen H.J., Hakola P., Repo E., Soininen H., Tiihonen J. Psychopathy and the posterior hippocampus. Behav Brain Res 2001, 118:187-193.
171. Lachman H.M., Pedrosa E., Petruolo O.A., Cockerham M., Papolos A., Novak T., Papolos D.F., Stopkova P. Increase in GSK3beta gene copy number variation in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2007, 144:259-265.
172. Lange C., Irle E. Enlarged amygdala volume and reduced hippocampal volume in young women with major depression. Psychol Med 2004, 34:1059-1064.
173. Lanquillon S., Krieg J.C., Bening-Abu-Shach U., Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000, 22:370-379.
174. Lanteaume L., Khalfa S., Regis J., Marquis P., Chauvel P., Bartolomei F. Emotion induction after direct intracerebral stimulations of human amygdala. Cereb Cortex 2007, 17:1307-1313.
175. Lau J.Y., Goldman D., Buzas B., Fromm S.J., Guyer A.E., Hodgkinson C., Monk C.S., Nelson E.E., Shen P.H., Pine D.S., Ernst M. Amygdala function and 5-HTT gene variants in adolescent anxiety and major depressive disorder. Biol Psychiatry 2009, 65:349-355.
176. Laursen T.M., Munk-Olsen T., Nordentoft M., Bo Mortensen P. A comparison of selected risk factors for unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia from a Danish population-based cohort. J Clin Psychiatry 2007, 68:1673-1681.
177. Law A.J., Pei Q., Walker M., Gordon-Andrews H., Weickert C.S., Feldon J., Pryce C.R., Harrison P.J. Early parental deprivation in the marmoset monkey produces Long-term changes in hippocampal expression of genes involved in synaptic plasticity and implicated in mood disorder. Neuropsychopharmacology 2009, 34:1381-1394.
178. Lawrence N.S., Williams A.M., Surguladze S., Giampietro V., Brammer M.J., Andrew C., Frangou S., Ecker C., Phillips M.L. Subcortical and ventral prefrontal cortical neural responses to facial expressions distinguish patients with bipolar disorder and major depression. Biol Psychiatry 2004, 55:578-587.
179. Lee A.L., Ogle W.O., Sapolsky R.M. Stress and depression: possible links to neuron death in the hippocampus. Bipolar Disord 2002, 4:117-128.
180. Lee B.T., Ham B.J. Serotonergic genes and amygdala activity in response to negative affective facial stimuli in Korean women. Genes Brain Behav 2008, 7:899-905.
181. Lee B.T., Ham B.J. Monoamine oxidase A-uVNTR genotype affects limbic brain activity in response to affective facial stimuli. Neuroreport 2008, 19:515-519.
182. Lee H.G., Perry G., Moreira P.I., Garrett M.R., Liu Q., Zhu X., Takeda A., Nunomura A., Smith M.A. Tau phosphorylation in Alzheimer's disease: pathogen or protector?. Trends Mol Med 2005, 11:164-169.
183. Lemonde S., Turecki G., Bakish D., Du L., Hrdina P.D., Bown C.D., Sequeira A., Kushwaha N., Morris S.J., Basak A., Ou X.M., Albert P.R. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 2003, 23:8788-8799.
184. Lenze E., Cross D., McKeel D., Neuman R.J., Sheline Y.I. White matter hyperintensities and gray matter lesions in physically healthy depressed subjects. Am J Psychiatry 1999, 156:1602-1607.
185. Lenze E.J., Shardell M., Ferrell R.E., Orwig D., Yu-Yahiro J., Hawkes W., Fredman L., Miller R., Magaziner J. Association of serotonin-1A and 2A receptor promoter polymorphisms with depressive symptoms and functional recovery in elderly persons after hip fracture. J Affect Disord 2008, 111:61-66.
186. Lesch K.P., Gutknecht L. Focus on the 5-HT1A receptor: emerging role of a gene regulatory variant in psychopathology and pharmacogenetics. Int J Neuropsychopharmacol 2004, 7:381-385.
187. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
188. Lewine R.R., Hudgins P., Brown F., Caudle J., Risch S.C. Differences in qualitative brain morphology findings in schizophrenia, major depression, bipolar disorder, and normal volunteers. Schizophr Res 1995, 15:253-259.
189. Li L., Ma N., Li Z., Tan L., Liu J., Gong G., Shu N., He Z., Jiang T., Xu L. Prefrontal white matter abnormalities in young adult with major depressive disorder: a diffusion tensor imaging study. Brain Res 2007, 1168:124-128.
190. Liu X., Cannon D.M., Drevets W., McMahon F.J. Genome-wide association study of PET scan phenotypes. Biol Psychiatry 2008, 186S.
191. Lloyd A.J., Ferrier I.N., Barber R., Gholkar A., Young A.H., O'Brien J.T. Hippocampal volume change in depression: late- and early-onset illness compared. Br J Psychiatry 2004, 184:488-495.
192. Lopez-Figueroa A.L., Norton C.S., Lopez-Figueroa M.O., Armellini-Dodel D., Burke S., Akil H., Lopez J.F., Watson S.J. Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biol Psychiatry 2004, 55:225-233.
193. Lopez J.F., Chalmers D.T., Little K.Y., Watson S.J. A.E. Bennett Research award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry 1998, 43:547-573.
194. Lowther S., De Paermentier F., Cheetham S.C., Crompton M.R., Katona C.L., Horton R.W. 5-HT1A receptor binding sites in postmortem brain samples from depressed suicides and controls. J Affect Disord 1997, 42:199-207.
195. Lupien S.J., Evans A., Lord C., Miles J., Pruessner M., Pike B., Pruessner J.C. Hippocampal volume is as variable in young as in older adults: implications for the notion of hippocampal atrophy in humans. Neuroimage 2007, 34:479-485.
196. Lyoo I.K., Streeter C.C., Ahn K.H., Lee H.K., Pollack M.H., Silveri M.M., Nassar L., Levin J.M., Sarid-Segal O., Ciraulo D.A., Renshaw P.F., Kaufman M.J. White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects. Psychiatry Res 2004, 131:135-145.
197. Ma N., Li L., Shu N., Liu J., Gong G., He Z., Li Z., Tan L., Stone W.S., Zhang Z., Xu L., Jiang T. White matter abnormalities in first-episode, treatment-naive young adults with major depressive disorder. Am J Psychiatry 2007, 164:823-826.
198. MacFall J.R., Payne M.E., Provenzale J.E., Krishnan K.R. Medial orbital frontal lesions in late-onset depression. Biol Psychiatry 2001, 49:803-806.
199. MacMaster F.P., Kusumakar V. Hippocampal volume in early onset depression. BMC Med 2004, 2:2.
200. MacMaster F.P., Mirza Y., Szeszko P.R., Kmiecik L.E., Easter P.C., Taormina S.P., Lynch M., Rose M., Moore G.J., Rosenberg D.R. Amygdala and hippocampal volumes in familial early onset major depressive disorder. Biol Psychiatry 2007, 63:385-390.
201. MacMaster F.P., Mirza Y., Szeszko P.R., Kmiecik L.E., Easter P.C., Taormina S.P., Lynch M., Rose M., Moore G.J., Rosenberg D.R. Amygdala and hippocampal volumes in familial early onset major depressive disorder. Biol Psychiatry 2008, 63:385-390.
202. MacQueen G.M., Campbell S., McEwen B.S., Macdonald K., Amano S., Joffe R.T., Nahmias C., Young L.T. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci U S A 2003, 100:1387-1392.
203. Mah L., Zarate C.A., Singh J., Duan Y.F., Luckenbaugh D.A., Manji H.K., Drevets W.C. Regional cerebral glucose metabolic abnormalities in bipolar II depression. Biol Psychiatry 2007, 61:765-775.
204. Malemud C.J., Miller A.H. Pro-inflammatory cytokine-induced SAPK/MAPK and JAK/STAT in rheumatoid arthritis and the new anti-depression drugs. Expert Opin Ther Targets 2008, 12:171-183.
205. Mannie Z.N., Bristow G.C., Harmer C.J., Cowen P.J. Impaired emotional categorisation in young people at increased familial risk of depression. Neuropsychologia 2007, 45:2975-2980.
206. Mannie Z.N., Norbury R., Murphy S.E., Inkster B., Harmer C.J., Cowen P.J. Affective modulation of anterior cingulate cortex in young people at increased familial risk of depression. Br J Psychiatry 2008, 192:356-361.
207. Manolio T.A., Brooks L.D., Collins F.S. A HapMap harvest of insights into the genetics of common disease. J Clin Invest 2008, 118:1590-1605.
208. Manuck S.B., Brown S.M., Forbes E.E., Hariri A.R. Temporal stability of individual differences in amygdala reactivity. Am J Psychiatry 2007, 164:1613-1614.
209. Marshall C.R., Noor A., Vincent J.B., Lionel A.C., Feuk L., Skaug J., Shago M., Moessner R., Pinto D., Ren Y., Thiruvahindrapduram B., Fiebig A., Schreiber S., Friedman J., Ketelaars C.E., Vos Y.J., Ficicioglu C., Kirkpatrick S., Nicolson R., Sloman L., Summers A., Gibbons C.A., Teebi A., Chitayat D., Weksberg R., Thompson A., Vardy C., Crosbie V., Luscombe S., Baatjes R., Zwaigenbaum L., Roberts W., Fernandez B., Szatmari P., Scherer S.W. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008, 82:477-488.
210. Matthews S.C., Strigo I.A., Simmons A.N., Yang T.T., Paulus M.P. Decreased functional coupling of the amygdala and supragenual cingulate is related to increased depression in unmedicated individuals with current major depressive disorder. J Affect Disord 2008, 111:13-20.
211. Mayberg H.S., Brannan S.K., Tekell J.L., Silva J.A., Mahurin R.K., McGinnis S., Jerabek P.A. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 2000, 48:830-843.
212. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., Schwalb J.M., Kennedy S.H. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45:651-660.
213. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., Silva J.A., Tekell J.L., Martin C.C., Lancaster J.L., Fox P.T. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999, 156:675-682.
214. McDonald C., Bullmore E.T., Sham P.C., Chitnis X., Wickham H., Bramon E., Murray R.M. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry 2004, 61:974-984.
215. McDonald W.M., Tupler L.A., Marsteller F.A., Figiel G.S., DiSouza S., Nemeroff C.B., Krishnan K.R. Hyperintense lesions on magnetic resonance images in bipolar disorder. Biol Psychiatry 1999, 45:965-971.
216. McEwen B.S., Magarinos A.M. Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders. Hum Psychopharmacol 2001, 16:S7-S19.
217. McKittrick C.R., Blanchard D.C., Blanchard R.J., McEwen B.S., Sakai R.R. Serotonin receptor binding in a colony model of chronic social stress. Biol Psychiatry 1995, 37:383-393.
218. McKittrick C.R., Magarinos A.M., Blanchard D.C., Blanchard R.J., McEwen B.S., Sakai R.R. Chronic social stress reduces dendritic arbors in CA3 of hippocampus and decreases binding to serotonin transporter sites. Synapse 2000, 36:85-94.
219. Meaney M.J., Szyf M. Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. Dialogues Clin Neurosci 2005, 7:103-123.
220. Meijer O.C., Cole T.J., Schmid W., Schutz G., Joels M., De Kloet E.R. Regulation of hippocampal 5-HT1A receptor mRNA and binding in transgenic mice with a targeted disruption of the glucocorticoid receptor. Brain Res Mol Brain Res 1997, 46:290-296.
221. Meltzer C.C., Price J.C., Mathis C.A., Butters M.A., Ziolko S.K., Moses-Kolko E., Mazumdar S., Mulsant B.H., Houck P.R., Lopresti B.J., Weissfeld L.A., Reynolds C.F. Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology 2004, 29:2258-2265.
222. Mendelson S.D., McEwen B.S. Autoradiographic analyses of the effects of restraint-induced stress on 5-HT1A, 5-HT1C and 5-HT2 receptors in the dorsal hippocampus of male and female rats. Neuroendocrinology 1991, 54:454-461.
223. Mervaala E., Fohr J., Kononen M., Valkonen-Korhonen M., Vainio P., Partanen K., Partanen J., Tiihonen J., Viinamaki H., Karjalainen A.K., Lehtonen J. Quantitative MRI of the hippocampus and amygdala in severe depression. Psychol Med 2000, 30:117-125.
224. Meyer J.H. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J Psychiatry Neurosci 2007, 32:86-102.
225. Meyer J.H., Houle S., Sagrati S., Carella A., Hussey D.F., Ginovart N., Goulding V., Kennedy J., Wilson A.A. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Arch Gen Psychiatry 2004, 61:1271-1279.
226. Mickey B.J., Ducci F., Hodgkinson C.A., Langenecker S.A., Goldman D., Zubieta J.K. Monoamine oxidase A genotype predicts human serotonin 1A receptor availability in vivo. J Neurosci 2008, 28:11354-11359.
227. Miller J.M., Oquendo M.A., Ogden R.T., Mann J.J., Parsey R.V. Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder. J Psychiatr Res 2008, 42:1137-1144.
228. Mondimore F.M., Zandi P.P., MacKinnon D.F., McInnis M.G., Miller E.B., Schweizer B., Crowe R.P., Scheftner W.A., Weissman M.M., Levinson D.F., DePaulo J.R., Potash J.B. A comparison of the familiality of chronic depression in recurrent early-onset depression pedigrees using different definitions of chronicity. J Affect Disord 2007, 100:171-177.
229. Monk C.S., Klein R.G., Telzer E.H., Schroth E.A., Mannuzza S., Moulton J.L., Guardino M., Masten C.L., McClure-Tone E.B., Fromm S., Blair R.J., Pine D.S., Ernst M. Amygdala and nucleus accumbens activation to emotional facial expressions in children and adolescents at risk for major depression. Am J Psychiatry 2008, 165:90-98.
230. Montag C., Reuter M., Newport B., Elger C., Weber B. The BDNF Val66Met polymorphism affects amygdala activity in response to emotional stimuli: evidence from a genetic imaging study. Neuroimage 2008, 42:1554-1559.
231. Moore G., Cortese B., Glitz D., Zajac-Benitez C., Quiroz J.A., Uhde T.W., Drevets W.C., Manji H.K. Chronic lithium increases prefrontal and subgenual prefrontal gray matter in patients with bipolar disorder: a longitudinal high resolution volumetric MRI study. J Clin Psychiatry 2008, in press.
232. Moorhead T.W., McKirdy J., Sussmann J.E., Hall J., Lawrie S.M., Johnstone E.C., McIntosh A.M. Progressive gray matter loss in patients with bipolar disorder. Biol Psychiatry 2007, 62:894-900.
233. Moses-Kolko E.L., Wisner K.L., Price J.C., Berga S.L., Drevets W.C., Hanusa B.H., Loucks T.L., Meltzer C.C. Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study. Fertil Steril 2008, 89:685-692.
234. Murata T., Kimura H., Omori M., Kado H., Kosaka H., Iidaka T., Itoh H., Wada Y. MRI white matter hyperintensities, (1)H-MR spectroscopy and cognitive function in geriatric depression: a comparison of early- and late-onset cases. Int J Geriatr Psychiatry 2001, 16:1129-1135.
235. h2, and Th3 cytokine alterations in major depression. J Affect Disord 2005, 88:167-173.
236. Nahas Z., Teneback C., Chae J.H., Mu Q., Molnar C., Kozel F.A., Walker J., Anderson B., Koola J., Kose S., Lomarev M., Bohning D.E., George M.S. Serial vagus nerve stimulation functional MRI in treatment-resistant depression. Neuropsychopharmacology 2007, 32:1649-1660.
237. Neff C.D., Abkevich V., Packer J.C., Chen Y., Potter J., Riley R., Davenport C., Degrado Warren J., Jammulapati S., Bhathena A., Choi W.S., Kroeger P.E., Metzger R.E., Gutin A., Skolnick M.H., Shattuck D., Katz D.A. Evidence for HTR1A and LHPP as interacting genetic risk factors in major depression. Mol Psychiatry 2008, in press.
238. Neumeister A., Wood S., Bonne O., Nugent A.C., Luckenbaugh D.A., Young T., Bain E.E., Charney D.S., Drevets W.C. Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects. Biol Psychiatry 2005, 57:935-937.
239. Neumeister A., Drevets W.C., Belfer I., Luckenbaugh D.A., Henry S., Bonne O., Herscovitch P., Goldman D., Charney D.S. Effects of an alpha 2C-adrenoreceptor gene polymorphism on neural responses to facial expressions in depression. Neuropsychopharmacology 2006, 31:1750-1756.
240. Neumeister A., Hu X.Z., Luckenbaugh D.A., Schwarz M., Nugent A.C., Bonne O., Herscovitch P., Goldman D., Drevets W.C., Charney D.S. Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. Arch Gen Psychiatry 2006, 63:978-986.
241. Neumeister A., Nugent A.C., Waldeck T., Geraci M., Schwarz M., Bonne O., Bain E.E., Luckenbaugh D.A., Herscovitch P., Charney D.S., Drevets W.C. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiatry 2004, 61:765-773.
242. Nobler M.S., Oquendo M.A., Kegeles L.S., Malone K.M., Campbell C.C., Sackeim H.A., Mann J.J. Decreased regional brain metabolism after ect. Am J Psychiatry 2001, 158:305-308.
243. Norbury R., Mackay C.E., Cowen P.J., Goodwin G.M., Harmer C.J. Short-term antidepressant treatment and facial processing. Functional magnetic resonance imaging study. Br J Psychiatry 2007, 190:531-532.
244. O'Brien J., Desmond P., Ames D., Schweitzer I., Harrigan S., Tress B. A magnetic resonance imaging study of white matter lesions in depression and Alzheimer's disease. Br J Psychiatry 1996, 168:477-485.
245. O'Brien J.T., Lloyd A., McKeith I., Gholkar A., Ferrier N. A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am J Psychiatry 2004, 161:2081-2090.
246. Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A 1998, 95:13290-13295.
247. Ongur D., Ferry A.T., Price J.L. Architectonic subdivision of the human orbital and medial prefrontal cortex. J Comp Neurol 2003, 460:425-449.
248. Onishchenko N., Karpova N., Sabri F., Castren E., Ceccatelli S. Long-lasting depression-like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercury. J Neurochem 2008, 106:1378-1387.
249. Osinsky R., Reuter M., Kupper Y., Schmitz A., Kozyra E., Alexander N., Hennig J. Variation in the serotonin transporter gene modulates selective attention to threat. Emotion 2008, 8:584-588.
250. Osuch E.A., Ketter T.A., Kimbrell T.A., George M.S., Benson B.E., Willis M.W., Herscovitch P., Post R.M. Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients. Biol Psychiatry 2000, 48:1020-1023.
251. Ovbiagele B., Saver J.L. Cerebral white matter hyperintensities on MRI: current concepts and therapeutic implications. Cerebrovasc Dis 2006, 22:83-90.
252. Pantel J., Schroder J., Essig M., Popp D., Dech H., Knopp M.V., Schad L.R., Eysenbach K., Backenstrass M., Friedlinger M. Quantitative magnetic resonance imaging in geriatric depression and primary degenerative dementia. J Affect Disord 1997, 42:69-83.
253. Parsey R.V., Oquendo M.A., Ogden R.T., Olvet D.M., Simpson N., Huang Y.Y., Van Heertum R.L., Arango V., Mann J.J. Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry 2006, 59:106-113.
254. Parsey R.V., Hastings R.S., Oquendo M.A., Huang Y.Y., Simpson N., Arcement J., Huang Y., Ogden R.T., Van Heertum R.L., Arango V., Mann J.J. Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am J Psychiatry 2006, 163:52-58.
255. Parsey R.V., Hastings R.S., Oquendo M.A., Hu X., Goldman D., Huang Y.Y., Simpson N., Arcement J., Huang Y., Ogden R.T., Van Heertum R.L., Arango V., Mann J.J. Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. Am J Psychiatry 2006, 163:48-51.
256. Patel A.B., de Graaf R.A., Mason G.F., Kanamatsu T., Rothman D.L., Shulman R.G., Behar K.L. Glutamatergic neurotransmission and neuronal glucose oxidation are coupled during intense neuronal activation. J Cereb Blood Flow Metab 2004, 24:972-985.
257. Paus T., Tomaiuolo F., Otaky N., MacDonald D., Petrides M., Atlas J., Morris R., Evans A.C. Human cingulate and paracingulate sulci: pattern, variability, asymmetry, and probabilistic map. Cereb Cortex 1996, 6:207-214.
258. Perroud N., Courtet P., Vincze I., Jaussent I., Jollant F., Bellivier F., Leboyer M., Baud P., Buresi C., Malafosse A. Interaction between BDNF Val66Met and childhood trauma on adult's violent suicide attempt. Genes Brain Behav 2008, 7:314-322.
259. Pezawas L., Verchinski B.A., Mattay V.S., Callicott J.H., Kolachana B.S., Straub R.E., Egan M.F., Meyer-Lindenberg A., Weinberger D.R. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 2004, 24:10099-10102.
260. Pezawas L., Meyer-Lindenberg A., Drabant E.M., Verchinski B.A., Munoz K.E., Kolachana B.S., Egan M.F., Mattay V.S., Hariri A.R., Weinberger D.R. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005, 8:828-834.
261. Pezawas L., Meyer-Lindenberg A., Goldman A.L., Verchinski B.A., Chen G., Kolachana B.S., Egan M.F., Mattay V.S., Hariri A.R., Weinberger D.R. Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Mol Psychiatry 2008, 13(654). 709-616.
262. Philibert R.A., Sandhu H., Hollenbeck N., Gunter T., Adams W., Madan A. The relationship of 5HTT (SLC6A4) methylation and genotype on mRNA expression and liability to major depression and alcohol dependence in subjects from the Iowa Adoption Studies. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:543-549.
263. Philibert R.A., Ryu G.Y., Yoon J.G., Sandhu H., Hollenbeck N., Gunter T., Barkhurst A., Adams W., Madan A. Transcriptional profiling of subjects from the Iowa adoption studies. Am J Med Genet B Neuropsychiatr Genet 2007, 144B:683-690.
264. Pizzagalli D.A., Oakes T.R., Fox A.S., Chung M.K., Larson C.L., Abercrombie H.C., Schaefer S.M., Benca R.M., Davidson R.J. Functional but not structural subgenual prefrontal cortex abnormalities in melancholia. Mol Psychiatry 2004, 325:393-405.
265. Posse S., Fitzgerald D., Gao K., Habel U., Rosenberg D., Moore G.J., Schneider F. Real-time fMRI of temporolimbic regions detects amygdala activation during single-trial self-induced sadness. Neuroimage 2003, 18:760-768.
266. Poulter M.O., Du L., Weaver I.C., Palkovits M., Faludi G., Merali Z., Szyf M., Anisman H. GABA(A) receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. Biol Psychiatry 2008, 64:645-652.
267. Praschak-Rieder N., Willeit M., Wilson A.A., Houle S., Meyer J.H. Seasonal variation in human brain serotonin transporter binding. Arch Gen Psychiatry 2008, 65:1072-1078.
268. Praschak-Rieder N., Kennedy J., Wilson A.A., Hussey D., Boovariwala A., Willeit M., Ginovart N., Tharmalingam S., Masellis M., Houle S., Meyer J.H. Novel 5HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study. Biol Psychiatry 2007, 62:327-331.
269. Radley J.J., Morrison J.H. Repeated stress and structural plasticity in the brain. Ageing Res Rev 2005, 4:271-287.
270. Raikkonen K., Pesonen A.K., Heinonen K., Kajantie E., Hovi P., Jarvenpaa A.L., Eriksson J.G., Andersson S. Depression in young adults with very low birth weight: the Helsinki study of very low-birth weight adults. Arch Gen Psychiatry 2008, 65:290-296.
271. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y., Overholser J.C., Roth B.L., Stockmeier C.A. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999, 45:1085-1098.
272. Rao H., Gillihan S.J., Wang J., Korczykowski M., Sankoorikal G.M., Kaercher K.A., Brodkin E.S., Detre J.A., Farah M.J. Genetic variation in serotonin transporter alters resting brain function in healthy individuals. Biol Psychiatry 2007, 62:600-606.
273. Reichenberg A., Gross R., Weiser M., Bresnahan M., Silverman J., Harlap S., Rabinowitz J., Shulman C., Malaspina D., Lubin G., Knobler H.Y., Davidson M., Susser E. Advancing paternal age and autism. Arch Gen Psychiatry 2006, 63:1026-1032.
274. Reif A., Rosler M., Freitag C.M., Schneider M., Eujen A., Kissling C., Wenzler D., Jacob C.P., Retz-Junginger P., Thome J., Lesch K.P., Retz W. Nature and nurture predispose to violent behavior: serotonergic genes and adverse childhood environment. Neuropsychopharmacology 2007, 32:2375-2383.
275. 11C]DASB PET study. Mol Psychiatry 2008, 13:557. 606-613.
276. 11C] (+)McN5652 shows increased serotonin transporter availability in major depression. J Affect Disord 2004, 82:321-327.
277. Rocher C., Spedding M., Munoz C., Jay T.M. Acute stress-induced changes in hippocampal/prefrontal circuits in rats: effects of antidepressants. Cereb Cortex 2004, 14:224-229.
278. Rusch B.D., Abercrombie H.C., Oakes T.R., Schaefer S.M., Davidson R.J. Hippocampal morphometry in depressed patients and control subjects: relations to anxiety symptoms. Biol Psychiatry 2001, 50:960-964.
279. Rydmark I., Wahlberg K., Ghatan P.H., Modell S., Nygren A., Ingvar M., Asberg M., Heilig M. Neuroendocrine, cognitive and structural imaging characteristics of women on long-term sick leave with job stress-induced depression. Biol Psychiatry 2006, 60:867-873.
280. Sachdev P., Brodaty H. Quantitative study of signal hyperintensities on T2-weighted magnetic resonance imaging in late-onset schizophrenia. Am J Psychiatry 1999, 156:1958-1967.
281. Salloway S., Malloy P., Kohn R., Gillard E., Duffy J., Rogg J., Tung G., Richardson E., Thomas C., Westlake R. MRI and neuropsychological differences in early- and late-life-onset geriatric depression. Neurology 1996, 46:1567-1574.
282. 11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 2000, 57:174-180.
283. Sassi R.B., Brambilla P., Nicoletti M., Mallinger A.G., Frank E., Kupfer D.J., Keshavan M.S., Soares J.C. White matter hyperintensities in bipolar and unipolar patients with relatively mild-to-moderate illness severity. J Affect Disord 2003, 77:237-245.
284. Savitz J., Drevets W.C. Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev doi:10.1016/j.neubiorev.2009.01.004.
285. Savitz J., Lucki I., Drevets W.C. 5-HT1A receptor function in major depressive disorder. Prog Neurobiol doi:10.1016/j.pneurobio.2009.01.009.
286. Savitz J., van der Merwe L., Stein D.J., Solms M., Ramesar R. Genotype and childhood sexual trauma moderate neurocognitive performance: a possible role for brain-derived neurotrophic factor and apolipoprotein E variants. Biol Psychiatry 2007, 62:391-399.
287. Savitz J.B., Ramesar R.S. Genetic variants implicated in personality: a review of the more promising candidates. Am J Med Genet B Neuropsychiatr Genet 2004, 131:20-32.
288. Savitz J.B., van der Merwe L., Newman T.K., Solms M., Stein D.J., Ramesar R.S. The relationship between childhood abuse and dissociation. Is it influenced by catechol-O-methyltransferase (COMT) activity?. Int J Neuropsychopharmacol 2008, 11:149-161.
289. Schiepers O.J., Wichers M.C., Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:201-217.
290. Schmidt L.A., Miskovic V., Boyle M.H., Saigal S. Shyness and timidity in young adults who were born at extremely low birth weight. Pediatrics 2008, 122:e181-e187.
291. Schneider F., Grodd W., Weiss U., Klose U., Mayer K.R., Nagele T., Gur R.C. Functional MRI reveals left amygdala activation during emotion. Psychiatry Res 1997, 76:75-82.
292. Schwartz C.E., Wright C.I., Shin L.M., Kagan J., Rauch S.L. Inhibited and uninhibited infants "grown up": adult amygdalar response to novelty. Science 2003, 300:1952-1953.
293. Seng K.C., Seng C.K. The success of the genome-wide association approach: a brief story of a long struggle. Eur J Hum Genet 2008, 16:554-564.
294. Sequeira A., Gwadry F.G., Ffrench-Mullen J.M., Canetti L., Gingras Y., Casero R.A., Rouleau G., Benkelfat C., Turecki G. Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry 2006, 63:35-48.
295. Sharp T., Boothman L., Raley J., Queree P. Important messages in the "post": recent discoveries in 5-HT neurone feedback control. Trends Pharmacol Sci 2007, 28:629-636.
296. Sheline Y.I. Hippocampal atrophy in major depression: a result of depression-induced neurotoxicity?. Mol Psychiatry 1996, 1:298-299.
297. Sheline Y.I., Gado M.H., Price J.L. Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport 1998, 9:2023-2028.
298. Sheline Y.I., Sanghavi M., Mintun M.A., Gado M.H. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 1999, 19:5034-5043.
299. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 1996, 93:3908-3913.
300. Sheline Y.I., Barch D.M., Donnelly J.M., Ollinger J.M., Snyder A.Z., Mintun M.A. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry 2001, 50:651-658.
301. Sheline Y.I., Price J.L., Vaishnavi S.N., Mintun M.A., Barch D.M., Epstein A.A., Wilkins C.H., Snyder A.Z., Couture L., Schechtman K., McKinstry R.C. Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors. Am J Psychiatry 2008, 165:524-532.
302. Shifman S., Johannesson M., Bronstein M., Chen S.X., Collier D.A., Craddock N.J., Kendler K.S., Li T., O'Donovan M., O'Neill F.A., Owen M.J., Walsh D., Weinberger D.R., Sun C., Flint J., Darvasi A. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet 2008, 4:e28.
303. Shifman S., Bhomra A., Smiley S., Wray N.R., James M.R., Martin N.G., Hettema J.M., An S.S., Neale M.C., van den Oord E.J., Kendler K.S., Chen X., Boomsma D.I., Middeldorp C.M., Hottenga J.J., Slagboom P.E., Flint J. A whole genome association study of neuroticism using DNA pooling. Mol Psychiatry 2008, 13:302-312.
304. Shively C.A., Friedman D.P., Gage H.D., Bounds M.C., Brown-Proctor C., Blair J.B., Henderson J.A., Smith M.A., Buchheimer N. Behavioral depression and positron emission tomography-determined serotonin 1A receptor binding potential in cynomolgus monkeys. Arch Gen Psychiatry 2006, 63:396-403.
305. Shulman R.G., Rothman D.L., Behar K.L., Hyder F. Energetic basis of brain activity: implications for neuroimaging. Trends Neurosci 2004, 27:489-495.
306. Siegle G.J., Steinhauer S.R., Thase M.E., Stenger V.A., Carter C.S. Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol Psychiatry 2002, 51:693-707.
307. Siegle G.J., Thompson W., Carter C.S., Steinhauer S.R., Thase M.E. Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features. Biol Psychiatry 2007, 61:198-209.
308. Sklar P., Smoller J.W., Fan J., Ferreira M.A., Perlis R.H., Chambert K., Nimgaonkar V.L., McQueen M.B., Faraone S.V., Kirby A., de Bakker P.I., Ogdie M.N., Thase M.E., Sachs G.S., Todd-Brown K., Gabriel S.B., Sougnez C., Gates C., Blumenstiel B., Defelice M., Ardlie K.G., Franklin J., Muir W.J., McGhee K.A., MacIntyre D.J., McLean A., VanBeck M., McQuillin A., Bass N.J., Robinson M., Lawrence J., Anjorin A., Curtis D., Scolnick E.M., Daly M.J., Blackwood D.H., Gurling H.M., Purcell S.M. Whole-genome association study of bipolar disorder. Mol Psychiatry 2008, 13:558-569.
309. Smith D.J., Harrison N., Muir W., Blackwood D.H. The high prevalence of bipolar spectrum disorders in young adults with recurrent depression: toward an innovative diagnostic framework. J Affect Disord 2005, 84:167-178.
310. Smolka M.N., Schumann G., Wrase J., Grusser S.M., Flor H., Mann K., Braus D.F., Goldman D., Buchel C., Heinz A. Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci 2005, 25:836-842.
311. Smolka M.N., Buhler M., Schumann G., Klein S., Hu X.Z., Moayer M., Zimmer A., Wrase J., Flor H., Mann K., Braus D.F., Goldman D., Heinz A. Gene-gene effects on central processing of aversive stimuli. Mol Psychiatry 2007, 12:307-317.
312. Smoller J.W., Paulus M.P., Fagerness J.A., Purcell S., Yamaki L.H., Hirshfeld-Becker D., Biederman J., Rosenbaum J.F., Gelernter J., Stein M.B. Influence of RGS2 on anxiety-related temperament, personality, and brain function. Arch Gen Psychiatry 2008, 65:298-308.
313. Sneed J.R., Rindskopf D., Steffens D.C., Krishnan K.R., Roose S.P. The vascular depression subtype: evidence of internal validity. Biol Psychiatry 2008, 64:491-497.
314. Sokolov B.P. Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies?. Int J Neuropsychopharmacol 2007, 1-9.
315. Steen R.G., Mull C., McClure R., Hamer R.M., Lieberman J.A. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry 2006, 188:510-518.
316. Steffens D.C., Byrum C.E., McQuoid D.R., Greenberg D.L., Payne M.E., Blitchington T.F., MacFall J.R., Krishnan K.R. Hippocampal volume in geriatric depression. Biol Psychiatry 2000, 48:301-309.
317. Stein M.B., Schork N.J., Gelernter J. Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders. Neuropsychopharmacology 2008, 33:312-319.
318. Stein M.B., Simmons A.N., Feinstein J.S., Paulus M.P. Increased amygdala and insula activation during emotion processing in anxiety-prone subjects. Am J Psychiatry 2007, 164:318-327.
319. Stewart C.A., Reid I.C. Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity. Psychopharmacology (Berl) 2000, 148:217-223.
320. Stewart W.F., Schwartz B.S., Davatzikos C., Shen D., Liu D., Wu X., Todd A.C., Shi W., Bassett S., Youssem D. Past adult lead exposure is linked to neurodegeneration measured by brain MRI. Neurology 2006, 66:1476-1484.
321. Stockmeier C.A., Shapiro L.A., Dilley G.E., Kolli T.N., Friedman L., Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J Neurosci 1998, 18:7394-7401.
322. Stockmeier C.A., Mahajan G.J., Konick L.C., Overholser J.C., Jurjus G.J., Meltzer H.Y., Uylings H.B., Friedman L., Rajkowska G. Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry 2004, 56:640-650.
323. Surguladze S.A., Elkin A., Ecker C., Kalidindi S., Corsico A., Giampietro V., Lawrence N., Deeley Q., Murphy D.G., Kucharska-Pietura K., Russell T.A., McGuffin P., Murray R., Phillips M.L. Genetic variation in the serotonin transporter modulates neural system-wide response to fearful faces. Genes Brain Behav 2008, 7:543-551.
324. Swanson L.W., Petrovich G.D. What is the amygdala?. Trends Neurosci 1998, 21:323-331.
325. Szeszko P.R., Lipsky R., Mentschel C., Robinson D., Gunduz-Bruce H., Sevy S., Ashtari M., Napolitano B., Bilder R.M., Kane J.M., Goldman D., Malhotra A.K. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry 2005, 10:631-636.
326. Takahashi T., Suzuki M., Tsunoda M., Kawamura Y., Takahashi N., Tsuneki H., Kawasaki Y., Zhou S.Y., Kobayashi S., Sasaoka T., Seto H., Kurachi M., Ozaki N. Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons. Neurosci Lett 2008, 435:34-39.
327. Takano A., Arakawa R., Hayashi M., Takahashi H., Ito H., Suhara T. Relationship between neuroticism personality trait and serotonin transporter binding. Biol Psychiatry 2007, 62:588-592.
328. Tang Y., Wang F., Xie G., Liu J., Li L., Su L., Liu Y., Hu X., He Z., Blumberg H.P. Reduced ventral anterior cingulate and amygdala volumes in medication-naive females with major depressive disorder: a voxel-based morphometric magnetic resonance imaging study. Psychiatry Res 2007, 156:83-86.
329. Taylor W.D., Steffens D.C., Payne M.E., MacFall J.R., Marchuk D.A., Svenson I.K., Krishnan K.R. Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression. Arch Gen Psychiatry 2005, 62:537-544.
330. Taylor W.D., MacFall J.R., Payne M.E., McQuoid D.R., Steffens D.C., Provenzale J.M., Krishnan R.R. Greater MRI lesion volumes in elderly depressed subjects than in control subjects. Psychiatry Res 2005, 139:1-7.
331. Tebartz van Elst L., Hesslinger B., Thiel T., Geiger E., Haegele K., Lemieux L., Lieb K., Bohus M., Hennig J., Ebert D. Frontolimbic brain abnormalities in patients with borderline personality disorder: a volumetric magnetic resonance imaging study. Biol Psychiatry 2003, 54:163-171.
332. Tsankova N.M., Berton O., Renthal W., Kumar A., Neve R.L., Nestler E.J. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 2006, 9:519-525.
333. Tupler L.A., Krishnan K.R., McDonald W.M., Dombeck C.B., D'Souza S., Steffens D.C. Anatomic location and laterality of MRI signal hyperintensities in late-life depression. J Psychosom Res 2002, 53:665-676.
334. Vaccarino V., Brennan M.L., Miller A.H., Bremner J.D., Ritchie J.C., Lindau F., Veledar E., Su S., Murrah N.V., Jones L., Jawed F., Dai J., Goldberg J., Hazen S.L. Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study. Biol Psychiatry 2008, 64:476-483.
335. Vakili K., Pillay S.S., Lafer B., Fava M., Renshaw P.F., Bonello-Cintron C.M., Yurgelun-Todd D.A. Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. Biol Psychiatry 2000, 47:1087-1090.
336. van der Veen F.M., Evers E.A., Deutz N.E., Schmitt J.A. Effects of acute tryptophan depletion on mood and facial emotion perception related brain activation and performance in healthy women with and without a family history of depression. Neuropsychopharmacology 2007, 32:216-224.
337. Verhagen M., van der Meij A., Franke B., Vollebergh W.A., de Graaf R., Buitelaar J.K., Janzing J.G. Familiality of major depressive disorder and patterns of lifetime comorbidity. The NEMESIS and GenMood studies: a comparison of three samples. Eur Arch Psychiatry Clin Neurosci 2008, 258:505-512.
338. Vollmayr B., Keck S., Henn F.A., Schloss P. Acute stress decreases serotonin transporter mRNA in the raphe pontis but not in other raphe nuclei of the rat. Neurosci Lett 2000, 290:109-112.
339. von Gunten A., Fox N.C., Cipolotti L., Ron M.A. A volumetric study of hippocampus and amygdala in depressed patients with subjective memory problems. J Neuropsychiatr Clin Neurosci 2000, 12:493-498.
340. Vyas A., Pillai A.G., Chattarji S. Recovery after chronic stress fails to reverse amygdaloid neuronal hypertrophy and enhanced anxiety-like behavior. Neuroscience 2004, 128:667-673.
341. Vyas A., Jadhav S., Chattarji S. Prolonged behavioral stress enhances synaptic connectivity in the basolateral amygdala. Neuroscience 2006, 143:387-393.
342. Vyas A., Mitra R., Shankaranarayana Rao B.S., Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci 2002, 22:6810-6818.
343. Vythilingam M., Heim C., Newport J., Miller A.H., Anderson E., Bronen R., Brummer M., Staib L., Vermetten E., Charney D.S., Nemeroff C.B., Bremner J.D. Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatry 2002, 159:2072-2080.
344. Wang L., LaBar K.S., McCarthy G. Mood alters amygdala activation to sad distractors during an attentional task. Biol Psychiatry 2006, 60:1139-1146.
345. Watanabe A., Tohyama Y., Nguyen K.Q., Hasegawa S., Debonnel G., Diksic M. Regional brain serotonin synthesis is increased in the olfactory bulbectomy rat model of depression: an autoradiographic study. J Neurochem 2003, 85:469-475.
346. Watkins P.C., Mathews A., Williamson D.A., Fuller R.D. Mood-congruent memory in depression: emotional priming or elaboration?. J Abnorm Psychol 1992, 101:581-586.
347. Weiss L.A., Shen Y., Korn J.M., Arking D.E., Miller D.T., Fossdal R., Saemundsen E., Stefansson H., Ferreira M.A., Green T., Platt O.S., Ruderfer D.M., Walsh C.A., Altshuler D., Chakravarti A., Tanzi R.E., Stefansson K., Santangelo S.L., Gusella J.F., Sklar P., Wu B.L., Daly M.J. Association between microdeletion and microduplication at 16p112 and autism. N Engl J Med 2008, 358:667-675.
348. Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature 2007, 447:661-678. Wellcome Trust Case Control Consortium.
349. Whitaker-Azmitia P.M., Druse M., Walker P., Lauder J.M. Serotonin as a developmental signal. Behav Brain Res 1996, 73:19-29.
350. Willeit M., Sitte H.H., Thierry N., Michalek K., Praschak-Rieder N., Zill P., Winkler D., Brannath W., Fischer M.B., Bondy B., Kasper S., Singer E.A. Enhanced serotonin transporter function during depression in seasonal affective disorder. Neuropsychopharmacology 2008, 33:1503-1513.
351. Williams J.H., Ross L. Consequences of prenatal toxin exposure for mental health in children and adolescents: a systematic review. Eur Child Adolesc Psychiatry 2007, 16:243-253.
352. Wong M.L., Dong C., Maestre-Mesa J., Licinio J. Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol Psychiatry 2008, 13:800-812.
353. Wong V. Occipital deep white matter hyperintensities in autism spectrum disorder. Pediatr Int 2007, 49:513-515.
354. Wu J., Buchsbaum M.S., Gillin J.C., Tang C., Cadwell S., Wiegand M., Najafi A., Klein E., Hazen K., Bunney W.E., Fallon J.H., Keator D. Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry 1999, 156:1149-1158.
355. Xu B., Roos J.L., Levy S., van Rensburg E.J., Gogos J.A., Karayiorgou M. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet 2008, 40:880-885.
356. Xu Y., Ku B., Tie L., Yao H., Jiang W., Ma X., Li X. Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB. Brain Res 2006, 1122:56-64.
357. Yang T.T., Simmons A.N., Matthews S.C., Tapert S.F., Frank G.K., Bischoff-Grethe A., Lansing A.E., Wu J., Brown G.G., Paulus M.P. Depressed adolescents demonstrate greater subgenual anterior cingulate activity. Neuroreport 2009, 20:440-444.
358. Yucel K., McKinnon M.C., Chahal R., Taylor V.H., Macdonald K., Joffe R., MacQueen G.M. Anterior cingulate volumes in never-treated patients with major depressive disorder. Neuropsychopharmacology 2008, 33:3157-3163.
359. Zeggini E., Scott L.J., Saxena R., Voight B.F., Marchini J.L., Hu T., de Bakker P.I., Abecasis G.R., Almgren P., Andersen G., Ardlie K., Bostrom K.B., Bergman R.N., Bonnycastle L.L., Borch-Johnsen K., Burtt N.P., Chen H., Chines P.S., Daly M.J., Deodhar P., Ding C.J., Doney A.S., Duren W.L., Elliott K.S., Erdos M.R., Frayling T.M., Freathy R.M., Gianniny L., Grallert H., Grarup N., Groves C.J., Guiducci C., Hansen T., Herder C., Hitman G.A., Hughes T.E., Isomaa B., Jackson A.U., Jorgensen T., Kong A., Kubalanza K., Kuruvilla F.G., Kuusisto J., Langenberg C., Lango H., Lauritzen T., Li Y., Lindgren C.M., Lyssenko V., Marvelle A.F., Meisinger C., Midthjell K., Mohlke K.L., Morken M.A., Morris A.D., Narisu N., Nilsson P., Owen K.R., Palmer C.N., Payne F., Perry J.R., Pettersen E., Platou C., Prokopenko I., Qi L., Qin L., Rayner N.W., Rees M., Roix J.J., Sandbaek A., Shields B., Sjogren M., Steinthorsdottir V., Stringham H.M., Swift A.J., Thorleifsson G., Thorsteinsdottir U., Timpson N.J., Tuomi T., Tuomilehto J., Walker M., Watanabe R.M., Weedon M.N., Willer C.J., Illig T., Hveem K., Hu F.B., Laakso M., Stefansson K., Pedersen O., Wareham N.J., Barroso I., Hattersley A.T., Collins F.S., Groop L., McCarthy M.I., Boehnke M., Altshuler D. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008, 40:638-645.
360. Zhou D., Grecksch G., Becker A., Frank C., Pilz J., Huether G. Serotonergic hyperinnervation of the frontal cortex in an animal model of depression, the bulbectomized rat. J Neurosci Res 1998, 54:109-116.
361. Zill P., Zwanzger P., Schule C., Minov C., Behrens S., Rupprecht R., Bondy B. Association study of a common polymorphism in the human 5HT1A receptor gene in major depression. Pharmacopsychiatry 2001, 34:238.
362. Zobel A., Jessen F., von Widdern O., Schuhmacher A., Hofels S., Metten M., Rietschel M., Scheef L., Block W., Becker T., Schild H.H., Maier W., Schwab S.G. Unipolar depression and hippocampal volume: impact of DNA sequence variants of the glucocorticoid receptor gene. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:836-843.
363. Zubenko G.S., Sullivan P., Nelson J.P., Belle S.H., Huff F.J., Wolf G.L. Brain imaging abnormalities in mental disorders of late life. Arch Neurol 1990, 47:1107-1111.
364. Zubenko G.S., Hughes H.B., Maher B.S., Stiffler J.S., Zubenko W.N., Marazita M.L. Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early-onset, major depression. Am J Med Genet 2002, 114:980-987.